Endothelial cells are a crucial component of the vascular system, responsible for maintaining the integrity, tone, and patency of blood vessels. They play a vital role in various physiological processes, including hemostasis and inflammatory responses. While a certain level of endothelial dysfunction leading to increased vascular permeability is necessary for controlling local infections, excessive dysfunction can have detrimental effects.
In the context of sepsis, a severe systemic response to infection, endothelial dysfunction becomes a key player in the development of organ dysfunction and failure. This dysfunction contributes to dysregulated inflammation, vascular leakage, and abnormal coagulation, all of which are hallmark features of sepsis-related complications. Recognizing the pivotal role of the vascular endothelium in sepsis pathogenesis, researchers have identified it as a promising target for therapeutic interventions aimed at improving outcomes for septic patients.
By focusing on restoring endothelial function and addressing the underlying mechanisms of dysfunction, potential treatments could help mitigate the harmful effects of sepsis on the body. Targeting the vascular endothelium holds promise for developing novel strategies to combat sepsis-related organ dysfunction and improve patient survival rates.
Sepsis-related Endothelial dysfunction includes glycocalyx shedding, nitrosative stress, and coagulation factors.